|
Total
|
Low MYSM1
|
High MYSM1
| | |
---|
Variable
|
N
|
%
|
N
|
%
|
N
|
%
|
χ2
|
P Valuea
|
---|
Survival
|
Alive
|
40
|
40.0
|
11
|
18.0
|
29
|
74.4
|
31.449
|
< 0.001
|
Deceased
|
60
|
60.0
|
50
|
82.0
|
10
|
25.6
| |
Pathological Diagnosis
|
Adjacent Normal Tissue
|
80
|
44.4
|
5
|
7.6
|
75
|
65.8
|
57.370
|
< 0.001
|
Carcinoma
|
100
|
55.6
|
61
|
92.4
|
39
|
34.2
| |
Histologic Subtypes
|
Adenocarcinoma
|
44
|
44.4
|
25
|
41.0
|
19
|
50.0
|
7.549
|
0.023
|
Tubular Adenocarcinoma
|
40
|
40.4
|
22
|
36.1
|
18
|
47.4
| |
Mucinous Adenocarcinoma
|
15
|
15.2
|
14
|
22.9
|
1
|
2.6
| |
Location
|
Ascending Colon
|
33
|
33.7
|
23
|
38.3
|
10
|
26.3
|
5.706
|
0.127
|
Transverse Colon
|
26
|
26.5
|
18
|
30.0
|
8
|
21.1
| |
Descending Colon
|
11
|
11.2
|
7
|
11.7
|
4
|
10.5
| |
Rectosigmoid Colon
|
28
|
28.6
|
12
|
20.0
|
16
|
42.1
| |
Age (y)
|
≤ 60
|
21
|
22.3
|
11
|
18.6
|
10
|
28.6
|
2.040
|
0.361
|
60–80
|
57
|
60.7
|
39
|
66.1
|
18
|
51.4
| |
≥ 80
|
16
|
17.0
|
9
|
15.3
|
7
|
20.0
| |
Gender
|
M
|
54
|
54.5
|
35
|
58.3
|
19
|
48.7
|
0.881
|
0.348
|
F
|
45
|
45.5
|
25
|
41.7
|
20
|
51.3
| |
Grade
|
< II
|
7
|
7.0
|
4
|
6.5
|
3
|
7.7
|
2.679
|
0.262
|
< III
|
78
|
78.0
|
45
|
73.8
|
33
|
84.6
| |
≥ III
|
15
|
15.0
|
12
|
19.7
|
3
|
7.7
| |
Stage
|
1
|
6
|
6.1
|
1
|
1.7
|
5
|
13.2
|
7.902
|
0.048
|
2
|
54
|
55.1
|
31
|
51.7
|
23
|
60.5
| |
3
|
35
|
35.7
|
26
|
43.3
|
9
|
23.7
| |
4
|
3
|
3.1
|
2
|
3.3
|
1
|
2.6
| |
Tumor Stage
|
≤ T2
|
7
|
7.3
|
2
|
3.4
|
5
|
13.5
|
6.741
|
0.034
|
T3
|
75
|
78.1
|
45
|
76.3
|
30
|
81.1
| |
T4
|
14
|
14.6
|
12
|
20.3
|
2
|
5.4
| |
Nodal Stage
|
N0
|
60
|
61.2
|
32
|
53.3
|
28
|
73.7
|
5.994
|
0.050
|
N1
|
27
|
27.6
|
18
|
30.0
|
9
|
23.7
| |
N2
|
11
|
11.2
|
10
|
16.7
|
1
|
2.6
| |
Metastasis
|
M0
|
97
|
97.0
|
59
|
96.7
|
38
|
97.4
|
0.042
|
0.838
|
M1
|
3
|
3.0
|
2
|
3.3
|
1
|
2.6
| |
- aThe P values were calculated in SPSS 25.0 using a chi-square test
- P values < 0.05 were considered to indicate statistical significance